Skip to main content
Top
Published in: Journal of Diabetes & Metabolic Disorders 2/2018

01-12-2018 | Research Article

Adherence to medications, self-care activity, and HbA1c status among patients with type 2 diabetes living in an urban area of Iran

Authors: Amir Jafarian-Amirkhizi, Amir Sarayani, Kheirollah Gholami, Maryam Taghizadeh-Ghehi, Kazem Heidari, Aarefeh Jafarzadeh-Kohneloo, Donald E. Morisky

Published in: Journal of Diabetes & Metabolic Disorders | Issue 2/2018

Login to get access

Abstract

Background

Appropriate pharmacotherapy, self-care and adherence to medications are crucial to diabetes control. We aimed to study the diabetes care and glycemic control in patients with type two diabetes living in an urban area of Iran.

Methods

In this cross-sectional study, patients with type 2 diabetes who attended a referral university affiliated community pharmacy and an accredited pathobiology laboratory in the 17th district of Tehran were evaluated. Data including demographics, medical and drug history were collected. Self-care activity (Diabetes Self-care Activity Measurement Scale) and medication adherence (8-item Morisky Medication Adherence scale) were also assessed. After completing the questionnaires, the patients were referred to the laboratory for Hemoglobin A1c test.

Results

Three hundred forty-eight patients (60.3% females) were recruited. The mean (SD) of patients’ age was 55.82 (12.72) and 75.3%of them were Illiterate or had primary education. Mean (SD) of Hemoglobin A1c levels was 8.39 (2.03) and 33% of patients had levels higher than 9%. Among study patients, 186 (53.4%) patients received monotherapy for diabetes type 2 and 200 (57.5%) patients had low adherence to medications. Physical activity, blood glucose self-monitoring and foot care were domains of self-care with the fewest practice. Re-using a pen or syringe needle more than once was reported by 83% of patients and mean (SD) time of re-using a pen needle was 9.11 (8.74).

Conclusion

Poor glycemic control, low medication adherence, inadequate self-care activities, signals of inappropriate pharmacotherapy and inadequate medical visits and monitoring in the study patients highlight the importance of providing accessible and affordable health care services in the region. Moreover, educational needs of the patients should be considered especially in an area in which the majority of patients are old and illiterate and have low socioeconomic status.
Literature
1.
go back to reference King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–31.CrossRefPubMed King H, Aubert RE, Herman WH. Global burden of diabetes, 1995–2025: prevalence, numerical estimates, and projections. Diabetes Care. 1998;21:1414–31.CrossRefPubMed
2.
go back to reference Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–21.CrossRefPubMed Whiting DR, Guariguata L, Weil C, Shaw J. IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract. 2011;94:311–21.CrossRefPubMed
3.
go back to reference Noshad S, Afarideh M, Heidari B, Mechanick JI, Esteghamati A. Diabetes Care in Iran: where we stand and where we are headed. Ann Glob Health. 2015;81:839–50.CrossRefPubMed Noshad S, Afarideh M, Heidari B, Mechanick JI, Esteghamati A. Diabetes Care in Iran: where we stand and where we are headed. Ann Glob Health. 2015;81:839–50.CrossRefPubMed
4.
go back to reference Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care. 2008;31:96–8.CrossRefPubMed Esteghamati A, Gouya MM, Abbasi M, Delavari A, Alikhani S, Alaedini F, et al. Prevalence of diabetes and impaired fasting glucose in the adult population of Iran: National Survey of Risk Factors for Non-Communicable Diseases of Iran. Diabetes Care. 2008;31:96–8.CrossRefPubMed
5.
go back to reference Haghdoost A, Rezazadeh-Kermani M, Sadghirad B, Baradaran H. Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis. East Mediterr Health J. 2009;15:591.CrossRefPubMed Haghdoost A, Rezazadeh-Kermani M, Sadghirad B, Baradaran H. Prevalence of type 2 diabetes in the Islamic Republic of Iran: systematic review and meta-analysis. East Mediterr Health J. 2009;15:591.CrossRefPubMed
6.
go back to reference Rashedi V, Asadi-Lari M, Delbari A, Fadayevatan R, Borhaninejad V, Foroughan M. Prevalence of diabetes type 2 in older adults: findings from a large population-based survey in Tehran, Iran (Urban HEART-2). Diabetes Metab Syndr. 2017. Rashedi V, Asadi-Lari M, Delbari A, Fadayevatan R, Borhaninejad V, Foroughan M. Prevalence of diabetes type 2 in older adults: findings from a large population-based survey in Tehran, Iran (Urban HEART-2). Diabetes Metab Syndr. 2017.
7.
go back to reference American Diabetes Association Standards of Medical Care in Diabetes—2017: Glycemic targets. Diabetes Care. 2017;40:S48–56. American Diabetes Association Standards of Medical Care in Diabetes2017: Glycemic targets. Diabetes Care. 2017;40:S48–56.
8.
go back to reference Sarayani A, Jahangard-Rafsanjani Z, Hadjibabaie M, Ahmadvand A, Javadi M, Gholami K. A comprehensive review of adherence to diabetes and cardiovascular medications in Iran; implications for practice and research. J Diabetes Metab Disord. 2013;12:57.CrossRefPubMedCentralPubMed Sarayani A, Jahangard-Rafsanjani Z, Hadjibabaie M, Ahmadvand A, Javadi M, Gholami K. A comprehensive review of adherence to diabetes and cardiovascular medications in Iran; implications for practice and research. J Diabetes Metab Disord. 2013;12:57.CrossRefPubMedCentralPubMed
9.
go back to reference Delavari A. Quality of care of diabetes mellitus type II patients in Iran. Arch Iran Med. 2009;12:492–5.PubMed Delavari A. Quality of care of diabetes mellitus type II patients in Iran. Arch Iran Med. 2009;12:492–5.PubMed
10.
go back to reference Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M. Adherence to glyburide and metformin and associated factors in type 2 diabetes in Isfahan, Iran. Iran J Pharm Res. 2011;10:933–9.PubMedCentralPubMed Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M. Adherence to glyburide and metformin and associated factors in type 2 diabetes in Isfahan, Iran. Iran J Pharm Res. 2011;10:933–9.PubMedCentralPubMed
11.
go back to reference Kheirandish M, Mahboobi H, Yazdanparast M, Kamal MA. Challenges related to glycemic control in type 2 diabetes mellitus patients. Curr Drug Metab. 2017;18:157–62.CrossRefPubMed Kheirandish M, Mahboobi H, Yazdanparast M, Kamal MA. Challenges related to glycemic control in type 2 diabetes mellitus patients. Curr Drug Metab. 2017;18:157–62.CrossRefPubMed
12.
go back to reference Sarayani A, Rashidian A, Gholami K. Low utilisation of diabetes medicines in Iran, despite their affordability (2000–2012): a time-series and benchmarking study. BMJ Open. 2014;4. Sarayani A, Rashidian A, Gholami K. Low utilisation of diabetes medicines in Iran, despite their affordability (2000–2012): a time-series and benchmarking study. BMJ Open. 2014;4.
13.
go back to reference Shahandeh K, Majdzadeh S, Kamali S, Pourmalek F, JamshidI E, Ghajarieh Sepanlou S, et al. Analysis of demographic and socioeconomic determinants of 17th zone Tehran: Tehran population lab region. Iran J Diabetes Metabol. 2004;3:5–10. Shahandeh K, Majdzadeh S, Kamali S, Pourmalek F, JamshidI E, Ghajarieh Sepanlou S, et al. Analysis of demographic and socioeconomic determinants of 17th zone Tehran: Tehran population lab region. Iran J Diabetes Metabol. 2004;3:5–10.
14.
go back to reference Larijani B, Mortaz Hejri S, Pour-Ebrahim R, Nouri M, Heshmat R, Shooshtarizadeh P, et al. Evaluation of type 2 diabetes and impaired fasting glucose (IFG) among 25-64 aged inhabitants of Tehran University of Medical Sciences Population lab Region. Iran J Diabetes Metabol. 2004;3:44–52. Larijani B, Mortaz Hejri S, Pour-Ebrahim R, Nouri M, Heshmat R, Shooshtarizadeh P, et al. Evaluation of type 2 diabetes and impaired fasting glucose (IFG) among 25-64 aged inhabitants of Tehran University of Medical Sciences Population lab Region. Iran J Diabetes Metabol. 2004;3:44–52.
15.
go back to reference Ghajarieh Sepanlou S, Majdzadeh S, Kamali S, Pourmalek F, Jamshidi E, Shahandeh K. Evaluation of the household expenses per capita and the inequity in people’s economic status and healthcare services. Iran J Diabetes Metabol. 2004;3:11–20. Ghajarieh Sepanlou S, Majdzadeh S, Kamali S, Pourmalek F, Jamshidi E, Shahandeh K. Evaluation of the household expenses per capita and the inequity in people’s economic status and healthcare services. Iran J Diabetes Metabol. 2004;3:11–20.
16.
go back to reference Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000;23:943–50.CrossRefPubMed Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000;23:943–50.CrossRefPubMed
17.
go back to reference Jahangard-Rafsanjani Z, Sarayani A, Nosrati M, Saadat N, Rashidian A, Hadjibabaie M, et al. Effect of a community pharmacist–delivered diabetes support program for patients receiving specialty medical care: a randomized controlled trial. Diabetes Educ. 2015;41:127–35.CrossRefPubMed Jahangard-Rafsanjani Z, Sarayani A, Nosrati M, Saadat N, Rashidian A, Hadjibabaie M, et al. Effect of a community pharmacist–delivered diabetes support program for patients receiving specialty medical care: a randomized controlled trial. Diabetes Educ. 2015;41:127–35.CrossRefPubMed
18.
go back to reference Shakibazadeh E, Rashidian A, Larijani B, Shojaeezadeh D, Forouzanfar M, Karimi Shahanjarini A. Perceived barriers and self-efficacy: impact on self-care behaviors in adults with type 2 diabetes. J Hayat. 2010;15:69–78. Shakibazadeh E, Rashidian A, Larijani B, Shojaeezadeh D, Forouzanfar M, Karimi Shahanjarini A. Perceived barriers and self-efficacy: impact on self-care behaviors in adults with type 2 diabetes. J Hayat. 2010;15:69–78.
19.
go back to reference Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:348–54.CrossRef Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens (Greenwich). 2008;10:348–54.CrossRef
20.
go back to reference Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence: response to authors. J Clin Epidemiol. 2011;64:255–63.CrossRefPubMed Morisky DE, DiMatteo MR. Improving the measurement of self-reported medication nonadherence: response to authors. J Clin Epidemiol. 2011;64:255–63.CrossRefPubMed
21.
go back to reference Dehghan M, Nayeri ND, Karimzadeh P, Iranmanesh S. Psychometric properties of the Persian version of the Morisky medication adherence scale-8. Br J Med Med Res. 2015;9:BJMMR.17345.CrossRef Dehghan M, Nayeri ND, Karimzadeh P, Iranmanesh S. Psychometric properties of the Persian version of the Morisky medication adherence scale-8. Br J Med Med Res. 2015;9:BJMMR.17345.CrossRef
22.
go back to reference Ghanei Gheshlagh R, Ebadi A, Veisi Raygani AK, Nourozi Tabrizi K, Dalvandi A, Mahmoodi H. Determining concurrent validity of the Morisky medication adherence scale in patients with type 2 diabetes. J Rehab Res Nurs. 2015;1:24–32. Ghanei Gheshlagh R, Ebadi A, Veisi Raygani AK, Nourozi Tabrizi K, Dalvandi A, Mahmoodi H. Determining concurrent validity of the Morisky medication adherence scale in patients with type 2 diabetes. J Rehab Res Nurs. 2015;1:24–32.
23.
go back to reference WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment 2017. Oslo, Norway; 2017. WHO Collaborating Centre for Drug Statistics Methodology, Guidelines for ATC classification and DDD assignment 2017. Oslo, Norway; 2017.
24.
go back to reference Bonakdaran S, Ebrahimzadeh S, Noghabi SH. Cardiovascular disease and risk factors in patients with type 2 diabetes mellitus in Mashhad, Islamic Republic of Iran. East Mediterr Health J. 2011;17:640–6.CrossRefPubMed Bonakdaran S, Ebrahimzadeh S, Noghabi SH. Cardiovascular disease and risk factors in patients with type 2 diabetes mellitus in Mashhad, Islamic Republic of Iran. East Mediterr Health J. 2011;17:640–6.CrossRefPubMed
25.
go back to reference Bergman U, Sjöqvist F. Measurement of drug utilization in Sweden: methodological and clinical implications. Acta Med Scand. 1984;215:15–22.CrossRef Bergman U, Sjöqvist F. Measurement of drug utilization in Sweden: methodological and clinical implications. Acta Med Scand. 1984;215:15–22.CrossRef
26.
go back to reference Lee W-Y, Ahn J, Kim J-H, Hong Y-P, Hong SK, Kim YT, et al. Reliability and validity of a self-reported measure of medication adherence in patients with type 2 diabetes mellitus in Korea. J Int Med Res. 2013;41:1098–110.CrossRefPubMed Lee W-Y, Ahn J, Kim J-H, Hong Y-P, Hong SK, Kim YT, et al. Reliability and validity of a self-reported measure of medication adherence in patients with type 2 diabetes mellitus in Korea. J Int Med Res. 2013;41:1098–110.CrossRefPubMed
27.
go back to reference Sakthong P, Chabunthom R, Charoenvisuthiwongs R. Psychometric properties of the Thai version of the 8-item Morisky medication adherence scale in patients with type 2 diabetes. Ann Pharmacother. 2009;43:950–7.CrossRefPubMed Sakthong P, Chabunthom R, Charoenvisuthiwongs R. Psychometric properties of the Thai version of the 8-item Morisky medication adherence scale in patients with type 2 diabetes. Ann Pharmacother. 2009;43:950–7.CrossRefPubMed
28.
go back to reference Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25:1015–21.CrossRefPubMed Schectman JM, Nadkarni MM, Voss JD. The association between diabetes metabolic control and drug adherence in an indigent population. Diabetes Care. 2002;25:1015–21.CrossRefPubMed
29.
go back to reference Tandon S, Chew M, Eklu-Gadegbeku CK, Shermock KM, Morisky DE. Validation and psychometric properties of the 8-item Morisky medication adherence scale (MMAS-8) in type 2 diabetes patients in sub-Saharan Africa. Diabetes Res Clin Pract. 2015;110:129–36.CrossRefPubMed Tandon S, Chew M, Eklu-Gadegbeku CK, Shermock KM, Morisky DE. Validation and psychometric properties of the 8-item Morisky medication adherence scale (MMAS-8) in type 2 diabetes patients in sub-Saharan Africa. Diabetes Res Clin Pract. 2015;110:129–36.CrossRefPubMed
30.
go back to reference Wang J, R-w B, Mo Y-z. Validation of the Chinese version of the eight-item Morisky medication adherence scale in patients with type 2 diabetes mellitus. J Clin Gerontol Geriatr. 2013;4:119–22.CrossRef Wang J, R-w B, Mo Y-z. Validation of the Chinese version of the eight-item Morisky medication adherence scale in patients with type 2 diabetes mellitus. J Clin Gerontol Geriatr. 2013;4:119–22.CrossRef
31.
go back to reference Al-Majed HT, Ismael AE, Al-Khatlan HM, El-Shazly MK. Adherence of type-2 diabetic patients to treatment. Kuwait Med J. 2014;46:225–32. Al-Majed HT, Ismael AE, Al-Khatlan HM, El-Shazly MK. Adherence of type-2 diabetic patients to treatment. Kuwait Med J. 2014;46:225–32.
32.
go back to reference García-Pérez L-E, Álvarez M, Dilla T, Gil-Guillén V, Orozco-Beltrán D. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther. 2013;4:175–94.CrossRefPubMedCentralPubMed García-Pérez L-E, Álvarez M, Dilla T, Gil-Guillén V, Orozco-Beltrán D. Adherence to therapies in patients with type 2 diabetes. Diabetes Ther. 2013;4:175–94.CrossRefPubMedCentralPubMed
33.
go back to reference Yurgin NR, Boye KS, Dilla T, Suriñach NL, Llach XB. Physician and patient management of type 2 diabetes and factors related to glycemic control in Spain. Patient Prefer Adherence. 2008;2:87–95.PubMedCentralPubMed Yurgin NR, Boye KS, Dilla T, Suriñach NL, Llach XB. Physician and patient management of type 2 diabetes and factors related to glycemic control in Spain. Patient Prefer Adherence. 2008;2:87–95.PubMedCentralPubMed
34.
go back to reference Yekta Z, Pourali R, Aghassi MR, Ashragh N, Ravanyar L, Rahim Pour MY. Assessment of self-care practice and its associated factors among diabetic patients in urban area of Urmia, northwest of Iran. J Res Health Sci. 2011;11:33–8.PubMed Yekta Z, Pourali R, Aghassi MR, Ashragh N, Ravanyar L, Rahim Pour MY. Assessment of self-care practice and its associated factors among diabetic patients in urban area of Urmia, northwest of Iran. J Res Health Sci. 2011;11:33–8.PubMed
35.
go back to reference Azizi F, Gouya M, Vazirian P, Dolatshahi P, Habibian S. The diabetes prevention and control programme of the Islamic Republic of Iran. East Mediterr Health J. 2003;9:1114–21.PubMed Azizi F, Gouya M, Vazirian P, Dolatshahi P, Habibian S. The diabetes prevention and control programme of the Islamic Republic of Iran. East Mediterr Health J. 2003;9:1114–21.PubMed
36.
go back to reference Moaatari M, Rezaee K, Mostafavi H, Zare N. Outcome of multiple usages of disposable insulin syringes in insulin dependent patients referring to Shahid Motahari Clinic in Shiraz. Res Med. 2005;29:307–12. Moaatari M, Rezaee K, Mostafavi H, Zare N. Outcome of multiple usages of disposable insulin syringes in insulin dependent patients referring to Shahid Motahari Clinic in Shiraz. Res Med. 2005;29:307–12.
37.
go back to reference Strauss K, Gols HD, Hannet I, Partanen T-M, Frid A. A pan-European epidemiologic study of insulin injection technique in patients with diabetes. Pract Diab Int. 2002;19:71–6.CrossRef Strauss K, Gols HD, Hannet I, Partanen T-M, Frid A. A pan-European epidemiologic study of insulin injection technique in patients with diabetes. Pract Diab Int. 2002;19:71–6.CrossRef
Metadata
Title
Adherence to medications, self-care activity, and HbA1c status among patients with type 2 diabetes living in an urban area of Iran
Authors
Amir Jafarian-Amirkhizi
Amir Sarayani
Kheirollah Gholami
Maryam Taghizadeh-Ghehi
Kazem Heidari
Aarefeh Jafarzadeh-Kohneloo
Donald E. Morisky
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Journal of Diabetes & Metabolic Disorders / Issue 2/2018
Electronic ISSN: 2251-6581
DOI
https://doi.org/10.1007/s40200-018-0356-4

Other articles of this Issue 2/2018

Journal of Diabetes & Metabolic Disorders 2/2018 Go to the issue